- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (191)
- Timeline of Article Publication (1)
- Authors Evaluation (4)
- Article Quality Tracking (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3702)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2023 (publication date) through Aug 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu Y. Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future. World J Gastroenterol 2023; 29(34): 5020-5037 [PMID: 37753366 DOI: 10.3748/wjg.v29.i34.5020] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i34/5020.htm |
| Number | Citing Articles |
| 1 |
Rongzhong Wang, Shiyan Wang, Hua Jiang, Yingmei Lan, Shaobin Yu. Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1430684
|
| 2 |
Young Seob Shin, Jeong Yun Jang, Ye Jin Yoo, Jesang Yu, Kye Jin Song, Yoon Young Jo, Sung-Bae Kim, Sook Ryun Park, Ho June Song, Yong-Hee Kim, Hyeong Ryul Kim, Jong Hoon Kim. Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goae060
|
| 3 |
Jindan Kai, Kai Kang, Zhixiao Jiang, Fei Xiong, Sheng Wang. Capivasertib reverses chemotherapy-induced esophageal cancer resistance via inhibiting Akt-associated Mcl-1 upregulation. Heliyon 2024; 10(13): e33567 doi: 10.1016/j.heliyon.2024.e33567
|
| 4 |
Junhan Wu, Xin Xia, Longlong Gong, Shujie Huang, Hongbo Zheng, Guibin Qiao, Yong Tang. Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration. Human Vaccines & Immunotherapeutics 2024; 20(1) doi: 10.1080/21645515.2024.2370085
|
| 5 |
Bo Yang, Wei Gou, Naiying Lan, Qing Shao, Weifeng Hu, Cheng Xue, Nanmei Liu. Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1347896
|
| 6 |
Mohamed Wishahi. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World Journal of Hepatology 2024; 16(4): 490-493 doi: 10.4254/wjh.v16.i4.490
|